Tags: HematologyBreast Cancer
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | Personalizing Treatments and Patient Education - 7 days ago Challenges in Adopting Novel Therapies - 28 days ago Real-World Considerations for New Therapies - 28 days ago Impact of Transplant Eligibility on Treatment Selection - about 1 month ago | |
| 2 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Scotland first in UK to approve new myeloma treatment - 2 months ago | |
| 3 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 4 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 5 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 1 month ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 4 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 9 months ago Futile Immunotherapy for Cancer Grows More Common - 11 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 12 months ago | |
| 6 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | ||
| 7 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 8 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 4 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 11 months ago | |
| 9 | Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. | ||
| 10 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland |